Lubiprostone for Treatment of Chronic Idiopathic Constipation

NCT02695719 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

156

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Idiopathic Constipation

Interventions

DRUG: Placebo
DRUG: Lubiprostone

Sponsor

Takeda